Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cellectar Biosciences, Inc.
Report date August 09, 2016 · Filed November 02, 2016
Section 16 reporting ended · disclosed 2016-11-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Cellectar Biosciences, Inc. common stock (CLRB)SEC Table I · non-derivative | Direct | 280,000 |
Reported balance
After 2016-10-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-10-31 · Sale · Disposed 21,000 · Balance 280,000 F1: CLRB stock sales during period October 13 through October 31, 2016 |
| Cellectar Biosciences Inc. Warrant (CLRBW)SEC Table II · derivative / convertible security · Conversion / exercise price $46.80 · Expires 2019-08-20 | Direct | 0 |
Reported balance
After 2016-08-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-08-09 · Sale · Disposed 40,916 · Balance 0 F2: Price of CLRB at close of market 11/1/2016 |
Filing footnotes · ownership attribution and instrument terms
F1: CLRB stock sales during period October 13 through October 31, 2016
F2: Price of CLRB at close of market 11/1/2016
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2016 Filed Nov 2, 2016 00:45 UTC | Cellectar Biosciences, Inc. clrB · Entity 7572 | SaleCellectar Biosciences, Inc. common stock (CLRB) | 21,000 | $2.03 | $42,609.00 |
DisclosureSEC source: 0001676051-16-000006 · primary_doc.xml · nonDerivative · entry 1 Hertzberg Richard · CIK 0001676051 · significant owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 F1 · security: CLRB stock sales during period October 13 through October 31, 2016 Read SEC document |
| August 09, 2016 Filed Nov 2, 2016 00:45 UTC | Cellectar Biosciences, Inc. clrB · Entity 7572 | SaleCellectar Biosciences Inc. Warrant (CLRBW) · Derivative | 40,916 | $1.75 Strike: $46.80 | $71,603.00 |
DisclosureSEC source: 0001676051-16-000006 · primary_doc.xml · derivative · entry 2 Hertzberg Richard · CIK 0001676051 · significant owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Cellectar Biosciences, Inc. common stock (CLRB) · 40,916 shares Expires 2019-08-20 F2 · security: Price of CLRB at close of market 11/1/2016 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.